ARC1B_HUMAN - dbPTM
ARC1B_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ARC1B_HUMAN
UniProt AC O15143
Protein Name Actin-related protein 2/3 complex subunit 1B
Gene Name ARPC1B {ECO:0000312|HGNC:HGNC:704}
Organism Homo sapiens (Human).
Sequence Length 372
Subcellular Localization Cytoplasm, cytoskeleton .
Protein Description Functions as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks..
Protein Sequence MAYHSFLVEPISCHAWNKDRTQIAICPNNHEVHIYEKSGAKWTKVHELKEHNGQVTGIDWAPESNRIVTCGTDRNAYVWTLKGRTWKPTLVILRINRAARCVRWAPNENKFAVGSGSRVISICYFEQENDWWVCKHIKKPIRSTVLSLDWHPNNVLLAAGSCDFKCRIFSAYIKEVEERPAPTPWGSKMPFGELMFESSSSCGWVHGVCFSASGSRVAWVSHDSTVCLADADKKMAVATLASETLPLLALTFITDNSLVAAGHDCFPVLFTYDAAAGMLSFGGRLDVPKQSSQRGLTARERFQNLDKKASSEGGTAAGAGLDSLHKNSVSQISVLSGGKAKCSQFCTTGMDGGMSIWDVKSLESALKDLKIK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAYHSFLVE
------CCCEEEEEC
15.67-
18AcetylationISCHAWNKDRTQIAI
CCEEEECCCCCEEEE
37.5723749302
18UbiquitinationISCHAWNKDRTQIAI
CCEEEECCCCCEEEE
37.57-
21PhosphorylationHAWNKDRTQIAICPN
EEECCCCCEEEECCC
34.1714749719
35PhosphorylationNNHEVHIYEKSGAKW
CCCEEEEEECCCCCE
11.4828152594
37AcetylationHEVHIYEKSGAKWTK
CEEEEEECCCCCEEE
36.9023749302
37UbiquitinationHEVHIYEKSGAKWTK
CEEEEEECCCCCEEE
36.90-
41AcetylationIYEKSGAKWTKVHEL
EEECCCCCEEEEEEH
59.9423749302
44AcetylationKSGAKWTKVHELKEH
CCCCCEEEEEEHHHH
40.2419608861
44UbiquitinationKSGAKWTKVHELKEH
CCCCCEEEEEEHHHH
40.2419608861
49UbiquitinationWTKVHELKEHNGQVT
EEEEEEHHHHCCEEE
54.68-
49MalonylationWTKVHELKEHNGQVT
EEEEEEHHHHCCEEE
54.6832601280
77PhosphorylationCGTDRNAYVWTLKGR
EECCCCEEEEEECCC
10.48-
80PhosphorylationDRNAYVWTLKGRTWK
CCCEEEEEECCCCCC
14.4622985185
82AcetylationNAYVWTLKGRTWKPT
CEEEEEECCCCCCCE
38.6823954790
82UbiquitinationNAYVWTLKGRTWKPT
CEEEEEECCCCCCCE
38.6821906983
85PhosphorylationVWTLKGRTWKPTLVI
EEEECCCCCCCEEEE
46.6520068231
87UbiquitinationTLKGRTWKPTLVILR
EECCCCCCCEEEEEE
27.75-
89PhosphorylationKGRTWKPTLVILRIN
CCCCCCCEEEEEEEC
29.9020068231
110UbiquitinationRWAPNENKFAVGSGS
EECCCCCCEECCCCC
28.6421890473
110AcetylationRWAPNENKFAVGSGS
EECCCCCCEECCCCC
28.6426051181
138UbiquitinationWWVCKHIKKPIRSTV
EEEEEECCCCCEEEE
52.82-
170PhosphorylationDFKCRIFSAYIKEVE
CCEEEEEEEEEHHHH
20.1420068231
172PhosphorylationKCRIFSAYIKEVEER
EEEEEEEEEHHHHCC
16.0128152594
174AcetylationRIFSAYIKEVEERPA
EEEEEEEHHHHCCCC
42.9323954790
174UbiquitinationRIFSAYIKEVEERPA
EEEEEEEHHHHCCCC
42.93-
183PhosphorylationVEERPAPTPWGSKMP
HHCCCCCCCCCCCCC
33.51-
187PhosphorylationPAPTPWGSKMPFGEL
CCCCCCCCCCCCCCE
23.1627251275
233AcetylationVCLADADKKMAVATL
EEEECCCHHHHHHHH
46.2825953088
289UbiquitinationGGRLDVPKQSSQRGL
CCCCCCCCCCHHCCC
63.76-
291PhosphorylationRLDVPKQSSQRGLTA
CCCCCCCCHHCCCCH
34.2722985185
292PhosphorylationLDVPKQSSQRGLTAR
CCCCCCCHHCCCCHH
22.7724719451
297PhosphorylationQSSQRGLTARERFQN
CCHHCCCCHHHHHHC
26.8822817900
3072-HydroxyisobutyrylationERFQNLDKKASSEGG
HHHHCHHHHHHCCCC
54.10-
307UbiquitinationERFQNLDKKASSEGG
HHHHCHHHHHHCCCC
54.10-
307AcetylationERFQNLDKKASSEGG
HHHHCHHHHHHCCCC
54.1027452117
308MalonylationRFQNLDKKASSEGGT
HHHCHHHHHHCCCCC
53.8432601280
308UbiquitinationRFQNLDKKASSEGGT
HHHCHHHHHHCCCCC
53.84-
310PhosphorylationQNLDKKASSEGGTAA
HCHHHHHHCCCCCCC
37.4929255136
311PhosphorylationNLDKKASSEGGTAAG
CHHHHHHCCCCCCCC
45.1623401153
315PhosphorylationKASSEGGTAAGAGLD
HHHCCCCCCCCCCCH
24.9621712546
323PhosphorylationAAGAGLDSLHKNSVS
CCCCCCHHHHCCCCC
37.1023403867
326UbiquitinationAGLDSLHKNSVSQIS
CCCHHHHCCCCCEEE
57.10-
326AcetylationAGLDSLHKNSVSQIS
CCCHHHHCCCCCEEE
57.1025953088
326MethylationAGLDSLHKNSVSQIS
CCCHHHHCCCCCEEE
57.10-
326MalonylationAGLDSLHKNSVSQIS
CCCHHHHCCCCCEEE
57.1026320211
328PhosphorylationLDSLHKNSVSQISVL
CHHHHCCCCCEEEEE
28.1320068231
330PhosphorylationSLHKNSVSQISVLSG
HHHCCCCCEEEEEEC
22.9320068231
333PhosphorylationKNSVSQISVLSGGKA
CCCCCEEEEEECCEE
14.9028857561
336PhosphorylationVSQISVLSGGKAKCS
CCEEEEEECCEEEHH
43.2625159151
339UbiquitinationISVLSGGKAKCSQFC
EEEEECCEEEHHHCC
48.47-
341UbiquitinationVLSGGKAKCSQFCTT
EEECCEEEHHHCCCC
37.59-
355PhosphorylationTGMDGGMSIWDVKSL
CCCCCCCCHHHHHHH
24.6522817900
360UbiquitinationGMSIWDVKSLESALK
CCCHHHHHHHHHHHH
47.02-
361PhosphorylationMSIWDVKSLESALKD
CCHHHHHHHHHHHHH
36.9020873877
364PhosphorylationWDVKSLESALKDLKI
HHHHHHHHHHHHCCC
44.1623312004
3672-HydroxyisobutyrylationKSLESALKDLKIK--
HHHHHHHHHCCCC--
61.81-
367MalonylationKSLESALKDLKIK--
HHHHHHHHHCCCC--
61.8126320211
367UbiquitinationKSLESALKDLKIK--
HHHHHHHHHCCCC--
61.81-
367AcetylationKSLESALKDLKIK--
HHHHHHHHHCCCC--
61.8125953088
370UbiquitinationESALKDLKIK-----
HHHHHHCCCC-----
59.59-
372UbiquitinationALKDLKIK-------
HHHHCCCC-------
53.34-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
21TPhosphorylationKinaseAURKAO14965
GPS
21TPhosphorylationKinasePAK1Q13153
PSP
21TPhosphorylationKinasePAK1O88643
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ARC1B_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ARC1B_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PAK1_HUMANPAK1physical
14749719
ARPC2_HUMANARPC2physical
20603326
AURKA_HUMANAURKAphysical
20603326
ARP3_HUMANACTR3physical
20603326
A4_HUMANAPPphysical
21832049
ARP3_HUMANACTR3physical
22939629
ARP2_HUMANACTR2physical
22939629
ARPC4_HUMANARPC4physical
22939629
ARPC2_HUMANARPC2physical
22939629
ARPC5_HUMANARPC5physical
22939629
ARPC3_HUMANARPC3physical
22939629
ARP5L_HUMANARPC5Lphysical
22939629
SYAC_HUMANAARSphysical
22863883
ARP2_HUMANACTR2physical
22863883
ARP3_HUMANACTR3physical
22863883
ARPC2_HUMANARPC2physical
22863883
ARPC3_HUMANARPC3physical
22863883
GON7_HUMANC14orf142physical
22863883
NC2B_HUMANDR1physical
22863883
HSF1_HUMANHSF1physical
22863883
IPO11_HUMANIPO11physical
22863883
2A5D_HUMANPPP2R5Dphysical
22863883
KAPCB_HUMANPRKACBphysical
22863883
RAGP1_HUMANRANGAP1physical
22863883
RFA2_HUMANRPA2physical
22863883
TPD54_HUMANTPD52L2physical
22863883
TPRKB_HUMANTPRKBphysical
22863883
UBE3A_HUMANUBE3Aphysical
22863883
PFD3_HUMANVBP1physical
22863883
ARPC2_HUMANARPC2physical
26186194
ARP5L_HUMANARPC5Lphysical
26186194
ARPC5_HUMANARPC5physical
26186194
ARP2_HUMANACTR2physical
26186194
ARPC3_HUMANARPC3physical
26186194
ARP3B_HUMANACTR3Bphysical
26186194
ARP3_HUMANACTR3physical
26186194
ARPC4_HUMANARPC4physical
26186194
POGK_HUMANPOGKphysical
26186194
NT5C_HUMANNT5Cphysical
26186194
ARP2_HUMANACTR2physical
26344197
ARP3_HUMANACTR3physical
26344197
ARPC2_HUMANARPC2physical
26344197
ARPC3_HUMANARPC3physical
26344197
ARPC5_HUMANARPC5physical
26344197
ARP5L_HUMANARPC5Lphysical
26344197
POGK_HUMANPOGKphysical
28514442
ARP3B_HUMANACTR3Bphysical
28514442
NT5C_HUMANNT5Cphysical
28514442
ARPC5_HUMANARPC5physical
28514442
ARP2_HUMANACTR2physical
28514442
ARPC2_HUMANARPC2physical
28514442
ARP3_HUMANACTR3physical
28514442
ARP5L_HUMANARPC5Lphysical
28514442
ARPC4_HUMANARPC4physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ARC1B_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-44 AND LYS-82, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310, AND MASSSPECTROMETRY.

TOP